Table 1.
Demographic characteristics of patients on antiretroviral therapy >1 year (n=1255)
| Total n (%) | |
|---|---|
| Sex | |
| Male | 828(66) |
| Female | 427(34) |
| Age | |
| <35 | 582(46) |
| ≥35 | 673(54) |
| Highest education level | |
| Never went to school | 93(7) |
| Primary(1–5) | 294(23) |
| Secondary(6–9) | 491(39) |
| High school(10–12) | 308(25) |
| College/university | 68(5) |
| Marital status | |
| Married | 788(63) |
| Divorced/widowed | 220(18) |
| Single | 247(20) |
| Currently lives with other people | |
| Alone | 80(6) |
| With other people | 1175(94) |
| Employment | |
| Working | 956(76) |
| Unemployed | 299(24) |
| HIV status of regular sex partner | |
| Negative/unknown | 502(40) |
| Positive | 384(31) |
| No regular partner | 343(27) |
| Refuse to answer | 26(2) |
| Time on antiretroviral therapy | |
| <3 years | 345(28) |
| 3–5 years | 551(44) |
| >5 years | 359(29) |
| Antiretroviral regimen | |
| TDF/3TC/EFV | 647(52) |
| TDF/3TC/NVP | 97(8) |
| ZDV/3TC/EFV | 164(13) |
| ZDV/3TC/NVP | 289(23) |
| 2 NRTI+LPV/r | 39(3) |
| others | 19(2) |
| Single-tablet regimen | |
| Yes | 637(51) |
| No | 618(49) |
TDF, tenofovir; 3TC, lamivudine; EFV, efavirenz, NVP, nevirapine; ZDV, zidovudine; NRTI, nucleoside reverse transcriptase inhibitor; LPV/r, lopinavir/ritonavir.